Information Provided By: 
Fly News Breaks for June 26, 2017
MDWD
Jun 26, 2017 | 07:36 EDT
SunTrust analyst Bruce Nudell raised his price target on MediWound after the company announced that the U.S. Biomedical Advanced Research and Development Authority, or BARDA, had indicated that it would exercise an option to fund the expansion of the company's NexoBrid indication. Nudell says that the cash the company looks set to receive from BARDA reduces its financial risk, while the exercise of the option would "modestly" lower the risk of NexoBrid. Nudell keeps a Buy rating on the stock.
News For MDWD From the Last 2 Days
There are no results for your query MDWD
